Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
Latest reported HRMY revenue for 2026-06-30 was $476.7M. Net income was $107.9M. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
Use this HRMY page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the HRMY quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the HRMY SEC filings page. Lician reads the product cache first so this HTML stays unique to Harmony Biosciences Holdings even when a live quote feed is slow.
Latest cached year on this hub. Full HRMY income, balance, and cash tables.